查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1301156

醫療保健合同製造市場規模、份額和趨勢分析報告：按類型、按最終用途、按地區、按細分市場，2023-2030 年

Healthcare Contract Manufacturing Market Size, Share & Trends Analysis Report By Type (Medical Devices, Pharmaceutical), By End-use (Medical Device Companies), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 175 Pages | 商品交期: 2-10個工作天內

價格

醫療保健合同製造市場的增長和趨勢

Grand View Research, Inc.最新報告顯示，到2030年，全球醫療保健合同製造市場規模預計將達到3475億美元，預測期內復合年增長率為9.5%。

不斷變化的監管環境和不斷增加的向新興國家的離岸外包預計將在預測期內推動醫療保健合同製造市場的增長。例如，2023年6月，FUJIFILM Diosynth Biotechnologies宣布將在東京開設銷售辦事處，為亞洲的製藥和生物技術公司提供先進療法和生物製劑的合同開發和製造服務。

隨著 COVID-19 等傳染病的出現，許多公司都在尋求加快生產以滿足不斷增長的需求。因此，這些公司正在聘請醫療保健首席營銷官來加快生產流程並降低總體成本，以滿足對醫療產品不斷增長的需求。全球開發針對 COVID-19 的疫苗和療法的努力為許多大型 CMO 以及小型 CMO 提供了最大的機會，因為製藥公司正在大規模生產疫苗劑量。因此，疫情對這個行業產生了積極的影響。

對先進產品的需求不斷增長也是推動行業規模擴大的因素之一。原始設備製造商 (OEM) 將醫療設備製造活動外包給第三方（主要是新興國家的第三方）以獲取經濟利益。此外，這些地區心臟病等慢性病的患病率不斷上升，這對市場增長產生了積極影響。報銷制度的變化是預計將增加原始設備製造商採用成本控制措施的一些關鍵因素。例如，為了確保報銷問題不會影響融資目標，設備製造商在產品開發早期制定周密的報銷策略以及監管和臨床策略。

醫療保健合同製造市場報告亮點

  • 由於製造預算較低且提供高度複雜的合同製造服務，製藥行業在 2022 年將佔據市場份額 65.1%。
  • 由於原始設備製造商降低成本和加快上市時間的壓力越來越大，醫療設備領域將成為增長最快的領域，複合年增長率為 9.7%。
  • 心髒病是醫療器械合同製造領域的主導類別，2022 年收入份額為 20.6%。
  • 由於服務提供商數量眾多、成本低廉以及醫療設備需求不斷增長，亞太地區預計從 2023 年到 2030 年將增長 10.6%。
  • 根據最終用途細分市場，製藥和生物製藥公司類別在 2022 年的收入份額最高，為 55.6%。高細分市場份額主要是由於全球生物製劑批准率不斷上升，推動了對大批量合同製造服務的需求。

目錄

第一章 調查方法和範圍

  • 市場細分和範圍
    • 段定義
    • 類型
    • 最終用途
  • 區域範圍
  • 估計/預測時間表
  • 目的
    • 目標1
    • 目標2
    • 目標 3
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
  • 信息或數據分析
    • 數據分析模型
  • 市場形成和驗證
  • 型號詳情
    • 產品流向分析
    • 母市場分析
  • 二級信息列表
  • 縮略語表

第二章執行摘要

  • 市場展望
  • 分部展望
  • 競爭考慮

3 醫療保健合同製造市場變量、趨勢和範圍

  • 市場譜系展望
    • 母公司市場展望
    • 相關/補充市場展望
  • 市場動態
    • 市場驅動力分析
    • 市場約束因素分析
    • 行業挑戰
  • 醫療保健合同製造市場分析工具
    • 行業分析 - 搬運工
    • PESTEL 分析
    • COVID-19 的影響分析

第四章 醫療保健合同製造市場：按類型細分分析

  • 醫療保健合同製造：2022 年和 2030 年市場份額分析
  • 醫療器材
    • 醫療器械市場，2018-2030（百萬美元）
    • 服務
    • 治療區
  • 藥品
    • 2018-2030 年醫藥市場（百萬美元）
    • 服務

5 醫療保健合同製造市場：按最終用途分類的細分分析

  • 醫療保健合同製造：2022 年和 2030 年市場份額分析
  • 醫療器械公司
    • 醫療器械企業市場，2018-2030（百萬美元）
  • 製藥和生物製藥公司
    • 2018-2030年製藥和生物製藥企業市場（百萬美元）
  • 其他
    • 其他市場，2018-2030（百萬美元）

6 醫療保健合同製造市場：區域分析

  • 2022 年和 2030 年區域市場份額分析
  • 區域市場儀表板
  • 全球區域市場快照
  • 北美
    • 2018-2030 年市場估算和預測（收入，百萬美元）
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
    • 比利時
    • 荷蘭
  • 亞太地區
    • 日本
    • 印度
    • 中國
    • 韓國
    • 澳大利亞
    • 泰國
    • 菲律賓
    • 馬來西亞
    • 新西蘭
    • 新加坡
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 智利
  • MEA
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 科威特
    • 以色列

第7章 競爭格局

  • 市場進入者分類
    • 創新者
    • 市場領導者
    • 啟動
    • 2022 年公司市場份額分析
  • 公司簡介
    • Nordson Corporation.
    • Integer Holdings Corporation
    • Jabil Inc.
    • Viant Technology LLC
    • FLEX LTD.
    • Celestica Inc.
    • Sanmina Corporation
    • Plexus Corp.
    • Phillips-Medisize
    • West Pharmaceutical Services, Inc.
    • Synecco Ltd.
    • Catalent, Inc.
    • Thermo Fisher Scientific Inc.
    • Recipharm AB.
    • Boehringer Ingelheim International GmbH
    • Lonza
    • Samsung Biologics
    • WuXi AppTec
    • FUJIFILM Diosynth Biotechnologies
    • Cambrex Corporation

第 8 章 意見領袖評論/建議

Product Code: GVR-3-68038-128-3

Healthcare Contract Manufacturing Market Growth & Trends

The global healthcare contract manufacturing market size is expected to reach USD 347.5 billion by 2030, expanding at a CAGR of 9.5% during the forecast period, according to a new report by Grand View Research, Inc. The changing regulatory landscape coupled with rising offshoring to emerging countries is anticipated to propel the healthcare contract manufacturing market growth over the forecast period. For instance, in June 2023, FUJIFILM Diosynth Biotechnologies announced to have a commercial office in Tokyo, offering contract development and manufacturing services for advanced therapies and biologics to Asian pharmaceutical and biotechnology companies.

Due to the emergence of infections, such as COVD-19 many organizations are attempting to accelerate production to meet the growing demand. Thus, these companies are appointing healthcare CMOs to speed up their production processes, as well as reduce their overall costs to meet the increasing demand for medical products. The worldwide effort to develop a vaccine and therapeutic agent against COVID-19 has created the greatest opportunity for many large as well as small CMOs as the pharmaceutical companies are manufacturing vaccine doses on large scale. Hence, the pandemic had a positive impact on this industry.

Increasing demand for advanced products is another factor driving the industry scale. Original Equipment Manufacturers (OEMs) are outsourcing the manufacturing activities of medical devices to third parties, mainly in developing countries to gain economic benefits. Furthermore, these regions are witnessing rising cases of chronic conditions such as heart disorders, thereby positively affecting the market growth. Changes in reimbursement schemes are some of the major factors anticipated to increase the adoption of cost containment measures by OEMs. For instance, to prevent reimbursement issues from impacting financing goals, device manufacturers are developing a well-planned reimbursement strategy in parallel with their regulatory and clinical strategies in the early phases of product development.

Healthcare Contract Manufacturing Market Report Highlights

  • The pharmaceutical segment dominated the market with a share of 65.1% in 2022 owing to a low manufacturing budget and highly sophisticated contract manufacturing service offerings
  • The medical devices segment is expected to be the fastest-growing segment with a CAGR of 9.7% owing to increasing pressure on OEMs to reduce costs and enhance the timeline for taking a product to market
  • Cardiology is the dominant category in the medical device contract manufacturing segment, with a revenue share of 20.6% in 2022, owing to the rising demand for cardiovascular devices as a result of the increasing prevalence of associated heart conditions
  • Asia Pacific is expected to witness lucrative growth of 10.6% from 2023 to 2030, owing to the presence of a large number of service providers, lower costs, and growing demand for medical devices in the region
  • Based on end use segment, the pharmaceutical and biopharmaceutical companies category held the highest revenue share of 55.6% in 2022. High segment shares are mainly due to the increasing rate of biologics approval across the globe, thereby boosting demand for its bulk production contract manufacturing services

Table of Content

Chapter 1. Research Methodology And Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment Definitions
    • 1.1.2. Type
    • 1.1.3. End Use
  • 1.2. Regional Scope
  • 1.3. Estimates And Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective-1
    • 1.4.2. Objective-2
    • 1.4.3. Objective-3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
    • 1.9.2. Parent Market Analysis
  • 1.10. List Of Secondary Sources
  • 1.11. List Of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Healthcare Contract Manufacturing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Implementation of international standards by contract manufacturers
      • 3.2.1.2. Drug shortage driving the demand for pharmaceutical development
      • 3.2.1.3. Commercial success of biologics for clinical use
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Regulatory and legal compliance
      • 3.2.2.2. Threat of information loss
    • 3.2.3. Industry Challenges
      • 3.2.3.1. Managing relationships
  • 3.3. Healthcare Contract Manufacturing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat Of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Healthcare Contract Manufacturing Market: Type Segment Analysis

  • 4.1 Healthcare Contract Manufacturing: Market Share Analysis, 2022 & 2030
  • 4.2 Medical Device
    • 4.2.1 Medical device market, 2018 - 2030 (USD Million)
    • 4.2.2 Service
      • 4.2.2.1 Accessories manufacturing
      • 4.2.2.1.1 Accessories manufacturing market, 2018 - 2030 (USD Million)
      • 4.2.2.2 Assembly manufacturing
      • 4.2.2.2.1 Assembly manufacturing market, 2018 - 2030 (USD Million)
      • 4.2.2.3 Component manufacturing
      • 4.2.2.3.1 Component manufacturing market, 2018 - 2030 (USD Million)
      • 4.2.2.4 Device manufacturing
      • 4.2.2.4.1 Device manufacturing market, 2018 - 2030 (USD Million)
    • 4.2.3 Therapeutic area
      • 4.2.3.1 Cardiology
      • 4.2.3.1.1 Cardiology market, 2018 - 2030 (USD Million)
      • 4.2.3.2 Diagnostic imaging
      • 4.2.3.2.1 Diagnostic imaging market, 2018 - 2030 (USD Million)
      • 4.2.3.3 Orthopedic
      • 4.2.3.3.1 Orthopedic market, 2018 - 2030 (USD Million)
      • 4.2.3.4 IVD
      • 4.2.3.4.1 IVD market, 2018 - 2030 (USD Million)
      • 4.2.3.5 Ophthalmic
      • 4.2.3.5.1 Ophthalmic market, 2018 - 2030 (USD Million)
      • 4.2.3.6 General & plastic surgery
      • 4.2.3.6.1 General & plastic surgery market, 2018 - 2030 (USD Million)
      • 4.2.3.7 Drug delivery
      • 4.2.3.7.1 Drug delivery market, 2018 - 2030 (USD Million)
      • 4.2.3.8 Dental
      • 4.2.3.8.1 Dental market, 2018 - 2030 (USD Million)
      • 4.2.3.9 Endoscopy
      • 4.2.3.9.1 Endoscopy market, 2018 - 2030 (USD Million)
      • 4.2.3.10 Diabetes care
      • 4.2.3.10.1 Diabetes care market, 2018 - 2030 (USD Million)
      • 4.2.3.11 Others
      • 4.2.3.11.1 Others market, 2018 - 2030 (USD Million)
  • 4.3 Pharmaceutical
    • 4.3.1 Pharmaceutical market, 2018 - 2030 (USD Million)
    • 4.3.2 Service
      • 4.3.2.1 API/bulk drugs
      • 4.3.2.1.1 API/bulk drugs market, 2018 - 2030 (USD Million)
      • 4.3.2.2 Advanced drug delivery formulations
      • 4.3.2.2.1 Advanced drug delivery formulations market, 2018 - 2030 (USD Million)
      • 4.3.2.3 Packaging
      • 4.3.2.3.1 Packaging market, 2018 - 2030 (USD Million)
      • 4.3.2.4 Finished dose formulations
      • 4.3.2.4.1 Finished dose formulations market, 2018 - 2030 (USD Million)
      • 4.3.2.4.2 Solid
      • 4.3.2.4.2.1 Solid market, 2018 - 2030 (USD Million)
      • 4.3.2.4.3 Liquid
      • 4.3.2.4.3.1 Liquid market, 2018 - 2030 (USD Million)
      • 4.3.2.4.4 Semisolid formulations
      • 4.3.2.4.4.1 Semisolid formulations market, 2018 - 2030 (USD Million)

Chapter 5. Healthcare Contract Manufacturing Market: End Use Segment Analysis

  • 5.1 Healthcare Contract Manufacturing: Market Share Analysis, 2022 & 2030
  • 5.2 Medical Device Companies
    • 5.2.1 Medical device companies market, 2018 - 2030 (USD Million)
  • 5.3 Pharmaceutical & Biopharmaceutical Companies
    • 5.3.1 Pharmaceutical & Biopharmaceutical Companies market, 2018 - 2030 (USD Million)
  • 5.4 Others
    • 5.4.1 Others market, 2018 - 2030 (USD Million)

Chapter 6. Healthcare Contract Manufacturing Market: Regional Analysis

  • 6.1. Regional Market Share Analysis, 2022 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. North America
    • 6.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
  • 6.5. Europe
    • 6.5.1. UK
      • 6.5.1.1. Key Country Dynamics
      • 6.5.1.2. Competitive Scenario
      • 6.5.1.3. Regulatory Framework
      • 6.5.1.4. UK Market Estimates and Forecasts, 2018 - 2030
    • 6.5.2. Germany
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Germany Market Estimates and Forecasts, 2018 - 2030
    • 6.5.3. France
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. France Market Estimates and Forecasts, 2018 - 2030
    • 6.5.4. Italy
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Italy Market Estimates and Forecasts, 2018 - 2030
    • 6.5.5. Spain
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Spain Market Estimates and Forecasts, 2018 - 2030
    • 6.5.6. Denmark
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Denmark Market Estimates and Forecasts, 2018 - 2030
    • 6.5.7. Sweden
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030
    • 6.5.8. Norway
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Competitive Scenario
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Norway Market Estimates and Forecasts, 2018 - 2030
    • 6.5.9. Belgium
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Competitive Scenario
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Belgium Market Estimates and Forecasts, 2018 - 2030
    • 6.5.10. Netherlands
      • 6.5.10.1. Key Country Dynamics
      • 6.5.10.2. Competitive Scenario
      • 6.5.10.3. Regulatory Framework
      • 6.5.10.4. Netherlands Market Estimates and Forecasts, 2018 - 2030
  • 6.6. Asia Pacific
    • 6.6.1. Japan
      • 6.6.1.1. Key Country Dynamics
      • 6.6.1.2. Competitive Scenario
      • 6.6.1.3. Regulatory Framework
      • 6.6.1.4. Japan Market Estimates and Forecasts, 2018 - 2030
    • 6.6.2. India
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. India Market Estimates and Forecasts, 2018 - 2030
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
    • 6.6.4. South Korea
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. South Korea Market Estimates and Forecasts, 2018 - 2030
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030
    • 6.6.6. Thailand
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Thailand Market Estimates and Forecasts, 2018 - 2030
    • 6.6.7. Philippines
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Competitive Scenario
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Philippines Market Estimates and Forecasts, 2018 - 2030
    • 6.6.8. Malaysia
      • 6.6.8.1. Key Country Dynamics
      • 6.6.8.2. Competitive Scenario
      • 6.6.8.3. Regulatory Framework
      • 6.6.8.4. Malaysia Market Estimates and Forecasts, 2018 - 2030
    • 6.6.9. New Zealand
      • 6.6.9.1. Key Country Dynamics
      • 6.6.9.2. Competitive Scenario
      • 6.6.9.3. Regulatory Framework
      • 6.6.9.4. New Zealand Market Estimates and Forecasts, 2018 - 2030
    • 6.6.10. Singapore
      • 6.6.10.1. Key Country Dynamics
      • 6.6.10.2. Competitive Scenario
      • 6.6.10.3. Regulatory Framework
      • 6.6.10.4. Singapore Market Estimates and Forecasts, 2018 - 2030
  • 6.7. Latin America
    • 6.7.1. Brazil
      • 6.7.1.1. Key Country Dynamics
      • 6.7.1.2. Competitive Scenario
      • 6.7.1.3. Regulatory Framework
      • 6.7.1.4. Brazil Market Estimates and Forecasts, 2018 - 2030
    • 6.7.2. Mexico
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Mexico Market Estimates and Forecasts, 2018 - 2030
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
    • 6.7.4. Colombia
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. Colombia Market Estimates and Forecasts, 2018 - 2030
    • 6.7.5. Chile
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. Chile Market Estimates and Forecasts, 2018 - 2030
  • 6.8. MEA
    • 6.8.1. South Africa
      • 6.8.1.1. Key Country Dynamics
      • 6.8.1.2. Competitive Scenario
      • 6.8.1.3. Regulatory Framework
      • 6.8.1.4. South Africa Market Estimates and Forecasts, 2018 - 2030
    • 6.8.2. Saudi Arabia
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
    • 6.8.3. UAE
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. UAE Market Estimates and Forecasts, 2018 - 2030
    • 6.8.4. Kuwait
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Competitive Scenario
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Kuwait Market Estimates and Forecasts, 2018 - 2030
    • 6.8.5. Israel
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Competitive Scenario
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Israel Market Estimates and Forecasts, 2018 - 2030

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
    • 7.1.1. Innovators
    • 7.1.2. Market Leaders
    • 7.1.3. Emerging Players
    • 7.1.4. Company Market Share Analysis, 2022
  • 7.2. Company Profiles
    • 7.2.1 Nordson Corporation.
      • 7.2.1.1 Company overview
      • 7.2.1.2 Financial performance
      • 7.2.1.3 Service benchmarking
      • 7.2.1.4 Strategic initiatives
    • 7.2.2 Integer Holdings Corporation
      • 7.2.2.1 Company overview
      • 7.2.2.2 Financial performance
      • 7.2.2.3 Service benchmarking
      • 7.2.2.4 Strategic initiatives
    • 7.2.3 Jabil Inc.
      • 7.2.3.1 Company overview
      • 7.2.3.2 Financial performance
      • 7.2.3.3 Service benchmarking
      • 7.2.3.4 Strategic initiatives
    • 7.2.4 Viant Technology LLC
      • 7.2.4.1 Company overview
      • 7.2.4.2 Service benchmarking
      • 7.2.4.3 Strategic initiatives
    • 7.2.5 FLEX LTD.
      • 7.2.5.1 Company overview
      • 7.2.5.2 Financial performance
      • 7.2.5.3 Service benchmarking
      • 7.2.5.4 Strategic initiatives
    • 7.2.6 Celestica Inc.
      • 7.2.6.1 Company overview
      • 7.2.6.2 Financial performance
      • 7.2.6.3 Service benchmarking
      • 7.2.6.4 Strategic initiatives
    • 7.2.7 Sanmina Corporation
      • 7.2.7.1 Company overview
      • 7.2.7.2 Financial performance
      • 7.2.7.3 Service benchmarking
      • 7.2.7.4 Strategic initiatives
    • 7.2.8 Plexus Corp.
      • 7.2.8.1 Company overview
      • 7.2.8.2 Financial performance
      • 7.2.8.3 Service benchmarking
      • 7.2.8.4 Strategic initiatives
    • 7.2.9 Phillips-Medisize
      • 7.2.9.1 Company overview
      • 7.2.9.2 Service benchmarking
      • 7.2.9.3 Strategic initiatives
    • 7.2.10 West Pharmaceutical Services, Inc.
      • 7.2.10.1 Company overview
      • 7.2.10.2 Financial performance
      • 7.2.10.3 Service benchmarking
      • 7.2.10.4 Strategic initiatives
    • 7.2.11 Synecco Ltd.
      • 7.2.11.1 Company overview
      • 7.2.11.2 Service benchmarking
    • 7.2.12 Catalent, Inc.
      • 7.2.12.1 Company overview
      • 7.2.12.2 Financial performance
      • 7.2.12.3 Service benchmarking
      • 7.2.12.4 Strategic initiatives
    • 7.2.13 Thermo Fisher Scientific Inc.
      • 7.2.13.1 Company overview
      • 7.2.13.2 Financial performance
      • 7.2.13.3 Service benchmarking
      • 7.2.13.4 Strategic initiatives
    • 7.2.14 Recipharm AB.
      • 7.2.14.1 Company overview
      • 7.2.14.2 Financial performance
      • 7.2.14.3 Service benchmarking
      • 7.2.14.4 Strategic initiatives
    • 7.2.15 Boehringer Ingelheim International GmbH
      • 7.2.15.1 Company overview
      • 7.2.15.2 Financial performance
      • 7.2.15.3 Service benchmarking
      • 7.2.15.4 Strategic initiatives
    • 7.2.16 Lonza
      • 7.2.16.1 Company overview
      • 7.2.16.2 Financial performance
      • 7.2.16.3 Service benchmarking
      • 7.2.16.4 Strategic initiatives
    • 7.2.17 Samsung Biologics
      • 7.2.17.1 Company overview
      • 7.2.17.2 Financial performance
      • 7.2.17.3 Service benchmarking
      • 7.2.17.4 Strategic initiatives
    • 7.2.18 WuXi AppTec
      • 7.2.18.1 Company overview
      • 7.2.18.2 Financial performance
      • 7.2.18.3 Service benchmarking
      • 7.2.18.4 Strategic initiatives
    • 7.2.19 FUJIFILM Diosynth Biotechnologies
      • 7.2.19.1 Company overview
      • 7.2.19.2 Financial performance
      • 7.2.19.3 Service benchmarking
      • 7.2.19.4 Strategic initiatives
    • 7.2.20 Cambrex Corporation
      • 7.2.20.1 Company overview
      • 7.2.20.2 Financial performance
      • 7.2.20.3 Service benchmarking
      • 7.2.20.4 Strategic initiatives

Chapter 8. KoL Commentary/Recommendations

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 North America Healthcare Contract Manufacturing market, by Countries, 2018 - 2030 (USD Million)
  • Table 4 North America Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 5 North America Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 6 U.S. Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 7 U.S. Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 8 Canada Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 9 Canada Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 10 Europe Healthcare Contract Manufacturing market, by Countries, 2018 - 2030 (USD Million)
  • Table 11 Europe Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 12 Europe Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 13 UK Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 14 UK Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 15 Germany Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 16 Germany Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 17 France Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 18 France Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 19 Italy Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 20 Italy Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 21 Spain Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 22 Spain Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 23 Denmark Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 24 Denmark Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 25 Sweden Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 26 Sweden Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 27 Norway Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 28 Norway Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 29 Belgium Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 30 Belgium Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 31 Netherlands Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 32 Netherlands Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific Healthcare Contract Manufacturing market, by Countries, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 36 China Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 37 China Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 38 Japan Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 39 Japan Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 40 India Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 41 India Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 42 Australia Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 43 Australia Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 44 South Korea Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 45 South Korea Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 46 Philippines Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 47 Philippines Healthcare Contract Manufacturing market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 48 Malaysia Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 49 Malaysia Healthcare Contract Manufacturing market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 50 Thailand Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 51 Thailand Healthcare Contract Manufacturing market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 52 New Zealand Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 53 New Zealand Healthcare Contract Manufacturing market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 54 Singapore Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 55 Singapore Healthcare Contract Manufacturing market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 56 Latin America Healthcare Contract Manufacturing market, by Countries, 2018 - 2030 (USD Million)
  • Table 57 Latin America Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 58 Latin America Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 59 Brazil Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 60 Brazil Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 61 Mexico Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 62 Mexico Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 63 Argentina Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 64 Argentina Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 65 Colombia Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 66 Colombia Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 67 Chile Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 68 Chile Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 69 Middle East and Africa Healthcare Contract Manufacturing market, by Countries, 2018 - 2030 (USD Million)
  • Table 70 Middle East and Africa Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 71 Middle East and Africa Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 72 South Africa Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 73 South Africa Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 74 Saudi Arabia Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 75 Saudi Arabia Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 76 UAE Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 77 UAE Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 78 Israel Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 79 Israel Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
  • Table 80 Kuwait Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
  • Table 81 Kuwait Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market research approaches
  • Fig. 4 QFD modelling for market share assessment
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Primary research pattern
  • Fig. 8 Primary interviews in North America
  • Fig. 9 Primary interviews in Europe
  • Fig. 10 Primary interviews in Asia Pacific
  • Fig. 11 Primary interviews in Latin America
  • Fig. 12 Primary interviews in MEA
  • Fig. 13 Market Snapshot
  • Fig. 14 Segment Snapshot
  • Fig. 15 Competitive Landscape Snapshot
  • Fig. 16 Healthcare Contract Manufacturing market segmentation
  • Fig. 17 Parent market outlook (2022)
  • Fig. 18 Related/ancillary market outlook (2022)
  • Fig. 19 Market driver relevance analysis (Current & future impact)
  • Fig. 20 Current shared End uses and outsourcing usage levels
  • Fig. 21 Market restraint relevance analysis (Current & future impact)
  • Fig. 22 Porter's five forces analysis
  • Fig. 23 SWOT analysis, by a factor (political & legal, economic and technological)
  • Fig. 24 Healthcare Contract Manufacturing Market Type outlook: Segment dashboard
  • Fig. 25 Healthcare Contract Manufacturing : Type movement analysis
  • Fig. 26 Medical devices market, 2018 - 2030 (USD Million)
  • Fig. 27 Medical devices market, by service, 2018 - 2030 (USD Million)
  • Fig. 28 Accessories manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 29 Assembly manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 30 Component manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 31 Device manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 32 Medical devices market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Fig. 33 Cardiology market, 2018 - 2030 (USD Million)
  • Fig. 34 Diagnostic imaging market, 2018 - 2030 (USD Million)
  • Fig. 35 Orthopedic market, 2018 - 2030 (USD Million)
  • Fig. 36 IVD market, 2018 - 2030 (USD Million)
  • Fig. 37 Ophthalmic market, 2018 - 2030 (USD Million)
  • Fig. 38 General & plastic surgery market, 2018 - 2030 (USD Million)
  • Fig. 39 Drug delivery market, 2018 - 2030 (USD Million)
  • Fig. 40 Dental market, 2018 - 2030 (USD Million)
  • Fig. 41 Endoscopy market, 2018 - 2030 (USD Million)
  • Fig. 42 Diabetes care market, 2018 - 2030 (USD Million)
  • Fig. 43 Others market, 2018 - 2030 (USD Million)
  • Fig. 44 Pharmaceuticals market, 2018 - 2030 (USD Million)
  • Fig. 45 Pharmaceuticals market, by Service, 2018 - 2030 (USD Million)
  • Fig. 46 API/Bulk Drugs market, 2018 - 2030 (USD Million)
  • Fig. 47 Advanced drug delivery formulations market, 2018 - 2030 (USD Million)
  • Fig. 48 Packaging market, 2018 - 2030 (USD Million)
  • Fig. 49 Finished dose formulation market, 2018 - 2030 (USD Million)
  • Fig. 50 Finished dose formulation market, by type, 2018 - 2030 (USD Million)
  • Fig. 51 Solid market, 2018 - 2030 (USD Million)
  • Fig. 52 Liquid market, 2018 - 2030 (USD Million)
  • Fig. 53 Semi-solid formulations market, 2018 - 2030 (USD Million)
  • Fig. 54 Healthcare Contract Manufacturing Market End use outlook: Segment dashboard
  • Fig. 55 Healthcare Contract Manufacturing : End use movement analysis
  • Fig. 56 Medical device companies market, 2018 - 2030 (USD Million)
  • Fig. 57 Pharmaceutical & Biopharmaceutical Companies market, 2018 - 2030 (USD Million)
  • Fig. 58 Others market, 2018 - 2030 (USD Million)
  • Fig. 59 Regional marketplace: Segment dashboard
  • Fig. 60 Regional outlook, 2022 & 2030
  • Fig. 61 North America market, 2018 - 2030 (USD Million)
  • Fig. 62 U.S. market, 2018 - 2030 (USD Million)
  • Fig. 63 Canada market, 2018 - 2030 (USD Million)
  • Fig. 64 Europe market, 2018 - 2030 (USD Million)
  • Fig. 65 Germany market, 2018 - 2030 (USD Million)
  • Fig. 66 UK market, 2018 - 2030 (USD Million)
  • Fig. 67 France market, 2018 - 2030 (USD Million)
  • Fig. 68 Italy market, 2018 - 2030 (USD Million)
  • Fig. 69 Spain market, 2018 - 2030 (USD Million)
  • Fig. 70 Denmark market, 2018 - 2030(USD Million)
  • Fig. 71 Sweden market, 2018 - 2030 (USD Million)
  • Fig. 72 Norway market, 2018 - 2030 (USD Million)
  • Fig. 73 Belgium market, 2018 - 2030 (USD Million)
  • Fig. 74 Netherlands market, 2018 - 2030 (USD Million)
  • Fig. 75 Asia Pacific market, 2018 - 2030 (USD Million)
  • Fig. 76 China market, 2018 - 2030 (USD Million)
  • Fig. 77 Japan market, 2018 - 2030 (USD Million)
  • Fig. 78 India market, 2018 - 2030 (USD Million)
  • Fig. 79 Australia market, 2018 - 2030 (USD Million)
  • Fig. 80 South Korea market, 2018 - 2030 (USD Million)
  • Fig. 81 Thailand market, 2018 - 2030 (USD Million)
  • Fig. 82 Philippines market, 2018 - 2030 (USD Million)
  • Fig. 83 Malaysia market, 2018 - 2030 (USD Million)
  • Fig. 84 New Zealand market, 2018 - 2030 (USD Million)
  • Fig. 85 Singapore market, 2018 - 2030 (USD Million)
  • Fig. 86 Latin America market, 2018 - 2030 (USD Million)
  • Fig. 87 Brazil market, 2018 - 2030 (USD Million)
  • Fig. 88 Mexico market, 2018 - 2030 (USD Million)
  • Fig. 89 Argentina market, 2018 - 2030 (USD Million)
  • Fig. 90 Colombia market, 2018 - 2030 (USD Million)
  • Fig. 91 Chile market, 2018 - 2030 (USD Million)
  • Fig. 92 Middle East & Africa market, 2018 - 2030 (USD Million)
  • Fig. 93 South Africa market, 2018 - 2030 (USD Million)
  • Fig. 94 Saudi Arabia market, 2018 - 2030 (USD Million)
  • Fig. 95 UAE market, 2018 - 2030 (USD Million)
  • Fig. 96 Kuwait market, 2018 - 2030 (USD Million)
  • Fig. 97 Israel market, 2018 - 2030 (USD Million)